EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

25 years of experience on the management of enterococcal infective endocarditis an observational study

Lorenz Schubert, Rui-Yang Chen, Matthias Weiss-Tessbach, Richard Kriz, Markus Obermüller, Matthias Jackwerth, Wolfgang Barousch, Heinz Burgmann, Manuel Kussmann, Ludwig Traby iD

Infection · 2025

DOI: 10.1007/s15010-024-02407-6 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Infection, 2025. Verfasst von Lorenz Schubert und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine I, Clinical Division of Infectious Diseases and Tropical Medicine, Medical University Vienna, Waehringer Guertel 18-20, Vienna…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Endocarditis, Bacterial, Enterococcus, Gram-Positive Bacterial Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Vienna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

As they are effective and well tolerated, aminopenicillins are still the cornerstone for the treatment of enterococcal infections. Current treatment guidelines for infective endocarditis (IE) recommend combination treatments, which carry a higher risk of adverse effects and are based on limited in vitro and experimental data. The aim of this study was therefore to evaluate the treatments of enterococcal IE in real-life practice.

Methods

A total of 4121 episodes of enterococcal bloodstream infections, occurring between 1994 and 2019, were screened for the evidence of IE. Baseline characteristics, risk factors for complicated infections and treatment information were assessed and analyzed using Cox regression analysis.

Results

Overall, 80 (3.9%) IE episodes were identified of which 78 were included in the final analysis. Treatment regimens in our cohort comprised aminopenicillin-monotherapy ( n = 20), teicoplanin-monotherapy ( n = 26), other monotherapies (OMT) ( n = 8), as well as combinations of ampicillin plus daptomycin ( n = 8), ampicillin plus gentamicin ( n = 4) or other combinations ( n = 9). Overall mortality at 28-days was low (9 of 75) and increased to (19 of 75) after 6-months. Frequency of moderate to severe valve regurgitation ( p = 0.89), or signs of uncontrolled infection ( p = 0.5) and vegetation size ≥ 10 mm ( p = 0.11) were similar in the treatment groups. None of the treatment groups was associated with increased hazard for IE-related mortality.

Conclusions

This retrospective study complements previous evidence, demonstrating that monotherapy regimens may be a suitable and effective option for the treatment of IE and supports the need for a prospective evaluation of aminopenicillin-monotherapy for initial and subsequent therapy in these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsEndocarditis, BacterialEnterococcusGram-Positive Bacterial InfectionsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedAmpicillinDaptomycinDrug Therapy, CombinationRetrospective StudiesRisk FactorsTreatment Outcome

Stichwörter der Autor:innen

Enterococcus faecalisEnterococcus faeciumInfective endocarditisMonotherapyMortality

Substanzen

AmpicillinAnti-Bacterial AgentsDaptomycin

Autor:innen und Institutionen

  • Department of Medicine I, Clinical Division of Infectious Diseases and Tropical Medicine, Medical University Vienna, Waehringer Guertel 18-20, Vienna, A-1090, Austria.
  • Medical Department with Nephrology & Dialysis, Klinik Ottakring Vienna, Vienna, Austria.
  • Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria.
  • Department of Laboratory Medicine, Division of Clinical Microbiology, Medical University of Vienna, Vienna, Austria.
  • Department of Medicine I, Clinical Division of Infectious Diseases and Tropical Medicine, Medical University Vienna, Waehringer Guertel 18-20, Vienna, A-1090, Austria. ludwig.traby@meduniwien.ac.at.

ORCID-Profile: Ludwig Traby

Förderung

  • Medical University of Vienna

Zitieren

APA

Schubert, L., Chen, R. Y., Weiss-Tessbach, M., Kriz, R., Obermüller, M., Jackwerth, M., Barousch, W., Burgmann, H., Kussmann, M., & Traby, L. (2025). 25 years of experience on the management of enterococcal infective endocarditis an observational study. Infection. https://doi.org/10.1007/s15010-024-02407-6

Vancouver

Schubert L, Chen RY, Weiss-Tessbach M, Kriz R, Obermüller M, Jackwerth M, et al. 25 years of experience on the management of enterococcal infective endocarditis an observational study. Infection. 2025. doi:10.1007/s15010-024-02407-6

BibTeX
@article{Schubert2025,
  author = {Schubert, Lorenz and Chen, Rui-Yang and Weiss-Tessbach, Matthias and Kriz, Richard and Obermüller, Markus and Jackwerth, Matthias and Barousch, Wolfgang and Burgmann, Heinz and Kussmann, Manuel and Traby, Ludwig},
  title = {25 years of experience on the management of enterococcal infective endocarditis an observational study},
  journal = {Infection},
  year = {2025},
  doi = {10.1007/s15010-024-02407-6}
}
Kostenlos starten →